Page 263 - Immunization Practices News Today

FACULTY Q&A Pfizer has delayed its FDA request for Emergency Use Authorization for the COVID-19 vaccine in children under 5, deciding to wait until full data are available with receipt of three doses. Data on the third dose are expected in April. Jason Pogue, clinical professor at the Un

Two shots of the kid-sized COVID-19 vaccines didn't protect 2 through 4-year-olds; the FDA is waiting for data about a third dose.

The travel vaccines market size is expected to grow from $3.07 Bn in 2021 to $5.91 Bn by 2028; it is estimated to grow at a CAGR of 9.8% during 2021–2028....

The safety and effectiveness data should prompt CDC to update its policy

Guidance also updated for people vaccinated outside the U.S., and following COVID treatment

By Jacqueline Howard, CNN The timeline for when children younger than 5 in the United States might start receiving Covid-19 vaccinations has just been

The Tuolumne County Public Health Report.

This report describes how local and systemic reactions and myocarditis are less frequent after a homologous COVID-19 booster dose.

CDC Director Rochelle Walensky says certain racial and age groups are falling behind in getting their COVID-19 booster shots.

The Centers for Disease Control and Prevention has released a report outlining how it develops its public health ...